Phoenix, AZ – November 5 2025 – Today, Governor Katie Hobbs announced that Arizona has submitted the state’s application for the federal government’s Rural Health Transformation Program alongside a bipartisan letter of support for the Governor’s plan. The program was designed to support health care access in rural communities through investments in health care workforce and technology.Continue reading
Category Archives: AZBio News
Mayo Clinic Launches Tool to Help Patients and Families Find Hospitals That Consistently Provide High-Quality Care.
Find trusted, high-quality hospitals nationwide with HealthLocatorContinue reading
Linda Bixby, PhD joins University of Arizona as Chief Research Partnerships Officer
Linda Bixby, PhD is the University of Arizona’s chief research partnerships officer. Bixby’s role focuses on scaling the university’s research enterprise and broadening its societal impact.Continue reading
Applications are Open for Arizona FAST Grants
The Arizona FAST Grant helps innovative small businesses prepare competitive proposals for federal SBIR/STTR funding. Eight Arizona-based companies will be selected to receive up to $3,000 each to hire an approved SBIR/STTR consultant. Applications close on Monday, November 24, 2025.
Ryan Touhill to Join City of Phoenix As Economic Development Director
The City of Phoenix is pleased to announce the appointment of Ryan Touhill as the new Community and Economic Development Director.
Touhill brings nearly two decades of experience in local government and economic development, most recently serving as Director of Arlington Economic Development (AED) in Virginia. There, he led the creation and implementation of AED’s Strategic Plan for Economic Growth, positioning Arlington as a leader in the region’s tech and innovation ecosystem. Under his leadership, AED secured millions in new investment and supported the creation of thousands of jobs, while launching successful initiatives such as the All In Arlington tourism campaign and policies to revitalize commercial districts.Continue reading
Tech Parks Arizona Drives $2.6 Billion Annual Economic Impact Fueling Thousands of High-Quality Jobs for Skilled Talent
TUCSON, Ariz. — Tech Parks Arizona celebrates a powerful economic legacy, reporting a $2.6 billion annual economic impact. The figure comes from a newly released analysis of 2024 data, the organization’s milestone 30th anniversary year, and conducted by the independent research firm Rounds Consulting Group. Every five years, Tech Parks Arizona undertakes a comprehensive assessment of its three innovation hubs: the UA Tech Park at Rita Road, UA Tech Park at The Bridges and the University of Arizona Center for Innovation (UACI). Continue reading
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
WASHINGTON— OCTOBER 29, 2025 — The U.S. Food and Drug Administration (FDA) today announced significant action to make it faster and less costly to develop biosimilar medicines, which are lower-cost “generic” alternatives to biologic drugs that treat serious and chronic diseases.Continue reading
AZBioPEERS – Getting The Word Out – Pitching Your Story
You’ve worked hard to build great company. You want to shout it from the rooftops, but will the right audience hear you? AZBioPEERS – Getting the Word Out – Pitching the Media features a discussion with 3 highly experienced life science PR professionals and former journalists. Watch the video to sit into their discussion.Continue reading
Dr. Eric Reiman receives Arizona’s highest bioscience honor
AZBio Pioneer Award for Lifetime Achievement recognizes groundbreaking contributions in fight against Alzheimer’sContinue reading
CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson’s Disease in Patients with Essential Tremor
SCOTTSDALE, AZ, October 22, 2025 – CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced that it has been awarded a $3 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to determine if the presence of the protein phosphorylated alpha-synuclein (P-SYN) in patients with essential tremor (ET) predicts the likelihood of developing Parkinson’s disease (PD). The company’s Syn-One Test® will be studied as a predictive tool to help assess which patients may be at risk for developing PD. Outcomes from the “Syn-T Study” could have major implications for the treatment and management of people with ET in the future.Continue reading